Dr Kristen Wilkinson, PSYD - Medicare Psychologist in Middleton, WI

Dr Kristen Wilkinson, PSYD is a medicare enrolled "Psychologist" provider in Middleton, Wisconsin. She went to Midwestern University, Chicago College Of Osteopathic Med and graduated in 2017 and has 7 years of diverse experience with area of expertise as Clinical Psychologist. She is a member of the group practice Borst Day And Associates Inc and her current practice location is 2365 Deming Way, Middleton, Wisconsin. You can reach out to her office (for appointments etc.) via phone at (608) 824-6160.

Dr Kristen Wilkinson is licensed to practice in Wisconsin (license number 5135) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1487116877.

Contact Information

Dr Kristen Wilkinson, PSYD
2365 Deming Way,
Middleton, WI 53562-5512
(608) 824-6160
(608) 827-3040



Healthcare Provider's Profile

Full NameDr Kristen Wilkinson
GenderFemale
SpecialityClinical Psychologist
Experience7 Years
Location2365 Deming Way, Middleton, Wisconsin
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Kristen Wilkinson attended and graduated from Midwestern University, Chicago College Of Osteopathic Med in 2017
  NPI Data:
  • NPI Number: 1487116877
  • Provider Enumeration Date: 04/03/2019
  • Last Update Date: 12/05/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 9931433281
  • Enrollment ID: I20190620002160

Medical Identifiers

Medical identifiers for Dr Kristen Wilkinson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487116877NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103T00000XPsychologist 5135 (Wisconsin)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Borst Day And Associates Inc55977316049

News Archive

ImmunoCellular receives FDA IND clearance for ICT-121 Phase I trial in glioblastoma multiforme

ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.

Reports examine issues of HIV treatment among prisoners, sex workers, sexual minorities in Zambia

"The recent arrest of Zambian HIV treatment and human rights advocate Paul Kasonkomona for only talking about legal barriers to HIV and other health services for Zambians who are prisoners, sex workers or members of sexual minorities, raises the question of how those barriers can be addressed by the country's board charged with distributing money from the Global Fund to Fight AIDS, Tuberculosis and Malaria" - the Country Coordinating Mechanism, the Center for Global Health Policy's "Science Speaks" blog writes.

Lower income, pregnant women may have increased risk for anemia

Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.

Harvard scientists to further advance blood-cleansing technology for treating sepsis

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.

People with MCI are impaired in several aspects of executive functioning

By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Kristen Wilkinson allows following entities to bill medicare on her behalf.
Entity NameBorst Day & Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619075140
PECOS PAC ID: 5597731604
Enrollment ID: O20040909000208

News Archive

ImmunoCellular receives FDA IND clearance for ICT-121 Phase I trial in glioblastoma multiforme

ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.

Reports examine issues of HIV treatment among prisoners, sex workers, sexual minorities in Zambia

"The recent arrest of Zambian HIV treatment and human rights advocate Paul Kasonkomona for only talking about legal barriers to HIV and other health services for Zambians who are prisoners, sex workers or members of sexual minorities, raises the question of how those barriers can be addressed by the country's board charged with distributing money from the Global Fund to Fight AIDS, Tuberculosis and Malaria" - the Country Coordinating Mechanism, the Center for Global Health Policy's "Science Speaks" blog writes.

Lower income, pregnant women may have increased risk for anemia

Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.

Harvard scientists to further advance blood-cleansing technology for treating sepsis

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.

People with MCI are impaired in several aspects of executive functioning

By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kristen Wilkinson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Kristen Wilkinson, PSYD
7974 Uw Health Ct,
Middleton, WI 53562-5531

Ph: () -
Dr Kristen Wilkinson, PSYD
2365 Deming Way,
Middleton, WI 53562-5512

Ph: (608) 824-6160

News Archive

ImmunoCellular receives FDA IND clearance for ICT-121 Phase I trial in glioblastoma multiforme

ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.

Reports examine issues of HIV treatment among prisoners, sex workers, sexual minorities in Zambia

"The recent arrest of Zambian HIV treatment and human rights advocate Paul Kasonkomona for only talking about legal barriers to HIV and other health services for Zambians who are prisoners, sex workers or members of sexual minorities, raises the question of how those barriers can be addressed by the country's board charged with distributing money from the Global Fund to Fight AIDS, Tuberculosis and Malaria" - the Country Coordinating Mechanism, the Center for Global Health Policy's "Science Speaks" blog writes.

Lower income, pregnant women may have increased risk for anemia

Lower income, urban women may be at increased risk for anemia during pregnancy if they live more than .25 miles, considered a "walking distance," from a healthy food source, according to a new study by researchers at Montefiore Medical Center.

Harvard scientists to further advance blood-cleansing technology for treating sepsis

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.

People with MCI are impaired in several aspects of executive functioning

By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?

Read more News

› Verified 9 days ago


Psychologist in Middleton, WI

Leah Barr, PHD
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 2711 Allen Blvd Ste 300, Middleton, WI 53562
Phone: 608-622-7030    
James K Gerndt, PHD
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 6300 University Ave, Suite 25, Middleton, WI 53562
Phone: 608-237-8000    Fax: 608-237-8005
Lisa B Mcguffey, PHD
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 3535 John Muir Dr, Middleton, WI 53562
Phone: 608-287-6084    
Dr. Katherine Anne Watermolen, PSY.D
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 2275 Deming Way Ste 180, Middleton, WI 53562
Phone: 608-282-8200    Fax: 608-262-9246
Dr. Margrett Christine Sampe, PH.D.
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 2275 Deming Way Ste 180, Middleton, WI 53562
Phone: 608-282-8200    Fax: 608-262-9246
Jane B. Gogan, PHD, ABPP
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 3015 Woodland Trl, Middleton, WI 53562
Phone: 608-467-3412    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.